Why DTC Drug Models Must Evolve From Access to True Patient Support

October 28, 2025

In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.